MEDICAL CANNABIS
Findings from the Freshleaf analysis suggests that the stigma surrounding cannabis is beginning to dissipate. The downscheduling of low dose CBD and the promise of access through pharmacies has given some legitimacy to cannabis as a ‘medicine for the masses’, and the jump in Authorised Prescribers (despite their overall numbers still being relatively small) signals that a growing number of doctors are starting to embrace cannabis prescribing.
pecial Access Scheme
